サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1304593

必須脂肪酸の世界市場-2023年～2030年

Global Essential Fatty Acids Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 102 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
必須脂肪酸の世界市場-2023年～2030年
出版日: 2023年07月07日
発行: DataM Intelligence
ページ情報: 英文 102 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

必須脂肪酸の世界市場は、2022年に46億米ドルに達し、2030年には85億米ドルに達するという有利な成長が予測されています。予測期間2023-2030年のCAGRは8.1%です。

世界的に健康とウェルネスへの関心が高まっており、全体的なウェルビーイングにおける栄養の重要性に対する消費者の意識が高まっています。消費者は、必須脂肪酸（EFA）を含む健康上の利点を提供する栄養介入食品やサプリメントを積極的に探しており、これが市場成長の原動力となっています。

このような動向の高まりが、EFA製品に対する世界の需要を牽引しています。さらに、EFAは栄養補助食品以外の用途、特に機能性食品や飲食品の分野でも利用されるようになっています。製造業者は、強化飲料、エネルギー・バー、シリアル、ベーカリー製品など、さまざまな製品にEFAを組み込んでいます。EFAを機能性食品に組み込むことで、消費者はEFAを手軽に取り入れることができます。消費者は普段の食生活にこれらの必須栄養素を便利に取り入れることができます。

市場力学

慢性疾患の増加が必須脂肪酸市場の成長を後押し

心血管疾患、糖尿病、肥満、神経障害などの慢性疾患の負担が増加する中、予防ヘルスケアに重点が置かれるようになっています。米国疾病予防管理センターによると、毎年、NCDsによって4,100万人が死亡しており、これは世界の10人のうち7人以上に相当します。消費者は健康管理に積極的になり、慢性疾患の発症リスクを減らす方法を求めるようになっています。その結果、総合的な健康をサポートし、慢性疾患のリスクを軽減する予防策として、必須脂肪酸（EFA）の需要が高まっています。

EFAは、様々な慢性疾患に対する潜在的な治療効果について幅広く研究されています。例えば、オメガ3脂肪酸は、心血管系疾患、関節炎、うつ病、認知機能低下といった症状の管理に有望な結果を示しています。EFAの治療可能性に関する認識が高まるにつれ、医療専門家や患者はEFAを治療計画や食事療法に取り入れるようになっています。このような認識の高まりが、市場におけるEFA需要の原動力となっています。

様々な産業におけるEFAの応用範囲の拡大が必須脂肪酸市場の成長を後押し

様々な産業におけるEFAの適用範囲の拡大は、市場を多様化させ、市場の成長を促進します。EFA、特にオメガ3脂肪酸は、製薬業界で大きな注目を集めています。これらの脂肪酸は、心血管疾患、炎症性疾患、精神疾患、神経変性疾患など、さまざまな健康状態において潜在的な治療効果を示しています。EFAは、パーソナルケアや化粧品業界でもますます活用されるようになっています。これらの脂肪酸は、皮膚の健康、保湿、アンチエイジングに役立っています。

必須脂肪酸、特にオメガ3脂肪酸は、乳幼児の発育に重要な役割を果たしています。脳の発達、認知機能、視力に不可欠です。EFAは動物の健康と福祉に不可欠です。EFAは、家畜や水産養殖種の成長を促進し、免疫機能を向上させ、全体的な健康を強化するために、動物用飼料の栄養補助食品として広く使用されています。それゆえ、医薬品、パーソナルケア、乳児栄養、動物飼料、機能性食品、栄養補助食品など、EFAの応用範囲の拡大が市場成長の原動力となっています。

原材料の入手が困難なことが必須脂肪酸市場の成長を抑制している

オメガ3脂肪酸のEPA（エイコサペンタエン酸）やDHA（ドコサヘキサエン酸）などのEFAは、主に魚類や藻類などの海洋生物から摂取されます。これらの供給源は、乱獲、環境条件、規制上の制限などの要因により、入手可能性が限られている場合があります。特定の供給源に依存することで、原料の入手可能性は変動やサプライチェーンの途絶に対して脆弱になります。この制約はEFAの生産と入手を制限し、市場の成長を妨げる可能性があります。

EFAsの原料の入手可能性は、季節変動や収穫における課題によって影響を受ける可能性があります。例えば、特定の魚種の収穫やオメガ3脂肪酸のための藻類の養殖は、特定の季節や地域に限定されることがあります。このため供給上の制約が生じ、年間を通じたEFAの安定生産に影響を及ぼす可能性があります。市場関係者は、原材料の安定供給を確保するために、こうした課題を克服しなければならないです。

COVID-19影響分析

COVID-19分析には、COVID前シナリオ、COVIDシナリオ、COVID後シナリオに加え、価格力学（COVID前シナリオと比較したパンデミック中およびパンデミック後の価格変動を含む）、需給スペクトラム（取引制限、封鎖、およびその後の問題による需給の変化）、政府の取り組み（政府機関による市場、セクター、産業を活性化するための取り組み）、メーカーの戦略的取り組み（COVID問題を緩和するためにメーカーが行ったことをここで取り上げる）が含まれます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • EFAの健康効果に対する意識の高まり
      • 栄養不足の増加
    • 抑制要因
      • 生産コストの高さ
    • 機会
      • 市場拡大と製品開拓
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

  • オメガ3
  • オメガ6
  • オメガ7
  • オメガ9

第8章 形状別

  • パウダー
  • シロップ
  • オイル
  • その他

第9章 供給源別

  • 植物油
  • 肉類
  • 魚類
  • 種子
  • ナッツ類
  • その他

第10章 用途別

  • 栄養補助食品
  • 乳児用調製粉乳
  • 医薬品
  • 化粧品
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Kemin Industries Inc,
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • KD Pharma Group
  • SEPPIC
  • Aker BioMarine AS
  • Koninklijke DSM NV
  • Croda International Plc
  • The Dow Chemical Company
  • Arbee Agencies
  • Arjuna Natural LLC
  • Arctic Nutrition

第14章 付録

目次
Product Code: FB6505

Market Overview

The Global Essential Fatty Acids Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 8.5 billion by 2030. The market is growing at a CAGR of 8.1% during the forecast period 2023-2030.

The global focus on health and wellness is growing, which has led to increased consumer awareness about the significance of nutrition in overall well-being. Consumers are actively searching for dietary interventions and supplements that provide health benefits including essential fatty acids (EFAs) which drive the market growth.

This increasing trend is driving the global demand for EFA products. Additionally, EFAs are being utilized in applications beyond dietary supplements, particularly in the functional foods and beverages sector. Manufacturers are incorporating EFAs into various products such as fortified beverages, energy bars, cereals, and bakery items. By integrating EFAs into functional foods. Consumers can conveniently include these essential nutrients in their regular diets

Market Dynamics

Increasing Prevalence of Chronic Diseases Fuels the growth of the Essential Fatty Acids Market

With the increasing burden of chronic diseases, such as cardiovascular diseases, diabetes, obesity, and neurological disorders, there is a growing emphasis on preventive healthcare. According to the Centers for Disease Control and Prevention, each year, NCDs kill 41 million people, which is equivalent to more than 7 out of 10 people worldwide. Consumers are becoming more proactive in managing their health and seeking ways to reduce the risk of developing chronic conditions. As a result, there is a higher demand for essential fatty acids (EFAs) as a preventive measure to support overall well-being and reduce the risk of chronic diseases.

EFAs have been extensively studied for their potential therapeutic effects on various chronic diseases. For example, Omega 3 fatty acids have shown promising results in managing conditions such as cardiovascular diseases, arthritis, depression, and cognitive decline. As awareness regarding the therapeutic potential of EFAs grows healthcare professionals and patients are incorporating EFAs into treatment plans and dietary regimens. This growing recognition drives the demand for EFAs in the market.

Expanding Application Scope of EFAs Across Various Industries Fuels the Market Growth Of Essential Fatty Acids

The expanding application scope of EFAs across various industries diversifies the market and fuels the market growth. EFAs, particularly Omega-3 fatty acids, have gained significant attention in the pharmaceutical industry. These fatty acids have shown potential therapeutic benefits in various health conditions such as cardiovascular diseases, inflammatory disorders, psychiatric disorders, and neurodegenerative diseases. EFAs are increasingly being utilized in the personal care and cosmetics industry. These fatty acids offer benefits for skin health, hydration, and anti-aging properties.

Essential fatty acids, especially Omega-3 fatty acids, play a crucial role in infant development. They are vital for brain development, cognitive function, and visual acuity. EFAs are essential for animal health and well-being. They are widely used as nutritional supplements in animal feed to promote growth, improve immune function, and enhance overall health in livestock and aquaculture species. Hence, EFA's expanding range of applications in pharmaceuticals, personal care, infant nutrition, animal feed, functional foods, and dietary supplements is driving its market growth.

Limited Availability of Raw Materials is Restraining the Market Growth Of Essential Fatty Acids Market

EFAs, such as Omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are predominantly sourced from marine organisms like fish and algae. These sources may have limited availability due to factors such as overfishing, environmental conditions, and regulatory restrictions. The reliance on specific sources makes the availability of raw materials vulnerable to fluctuations and supply chain disruptions. This constraint can limit the production and availability of EFAs, hindering market growth.

The availability of raw materials for EFAs can be affected by seasonal variations and challenges in harvesting. For example, the harvesting of certain fish species or the cultivation of algae for Omega-3 fatty acids may be limited to specific seasons or regions. This can create supply constraints and impact the consistent production of EFAs throughout the year. Market players must navigate these challenges to ensure a stable supply of raw materials.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global essential fatty acids market is segmented based on product type, form, application, distribution channel, and region.

The Abundance of Omega-3 Fatty Acids in Fish

Based on source, essential fatty acids are classified into vegetable oils, meat, fish, seeds, nuts, and others.

In 2022, fish had the highest share in the essential fatty acids market. The fish segment is commonly recognized as one of the significant sources of Essential Fatty Acids (EFAs), particularly Omega-3 fatty acids. Fish, especially fatty fish like salmon, mackerel, and sardines, are known for their high Omega-3 content, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). As a result, the fish segment often holds a prominent share in the EFAs market.

Fatty fish species are known to naturally accumulate Omega-3 fatty acids in their tissues. This natural abundance makes fish a valuable source for extracting EFAs, particularly EPA and DHA. The high Omega-3 content in fish contributes to the segment's significant market share.

Geographical Analysis

Growing Awareness of the Role of EFAs in the Asia-Pacific Region

In 2022, Asia Pacific has a significant share of the EFAs market. According to the Department of Biotechnology, India, India has the highest number of people with Diabetes in the world with around 77 million living with diabetes and a projection of 134 million by 2045 (International Diabetes Federation). India suffers loss of life at an early age due to cardiovascular disease which accounts for one-fourth of all deaths. EFAs, particularly Omega-3 fatty acids, have been extensively studied for their potential cardiovascular benefits, including reducing triglyceride levels, improving heart health, and managing blood pressure. The growing awareness of the role of EFAs drives the demand for EFAs products in the region.

Many countries in the Asia Pacific region have a long history of consuming Omega-3-rich foods, such as fish and seafood. Traditional diets in countries like Japan and South Korea include a significant amount of fish, which naturally provides Omega-3 fatty acids. This cultural preference and familiarity with Omega-3-rich foods contribute to the demand for EFAs in the region.

Competitive Landscape

The major global players include: Kemin Industries, Inc, KD Pharma Group, SEPPIC, Aker BioMarine AS, Koninklijke DSM NV, Croda International Plc, The Dow Chemical Company, Arbee Agencies, Arjuna Natural LLC, Arctic Nutrition.

Why Purchase the Report?

  • To visualize the global Essential Fatty Acids extract market segmentation based on product type, form, source, application, and region understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous Essential Fatty Acids extract market-level data points all for segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Global Essential Fatty Acids Extract Market Report Would Provide Approximately 69 Tables, 74 Figures And 102 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Source
  • 3.4. Snippet by Application
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Awareness of the Health Benefits of EFAs
      • 4.1.1.2. Increasing Nutritional Deficiencies
    • 4.1.2. Restraints
      • 4.1.2.1. The High Cost of Production
    • 4.1.3. Opportunity
      • 4.1.3.1. Market Expansion and Product Development
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Omega 3*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Omega 6
  • 7.4. Omega 7
  • 7.5. Omega 9

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Powder*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Syrup
  • 8.4. Oil
  • 8.5. Others

9. By Source

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.1.2. Market Attractiveness Index, By Source
  • 9.2. Vegetable Oils*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Meat
  • 9.4. Fish
  • 9.5. Seeds
  • 9.6. Nuts
  • 9.7. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Nutraceuticals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Infant Formula
  • 10.4. Pharmaceuticals
  • 10.5. Cosmetics
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

    • 13.1.1. Kemin Industries Inc,*
    • 13.1.2. Company Overview
    • 13.1.3. Product Portfolio and Description
    • 13.1.4. Financial Overview
    • 13.1.5. Key Developments
  • 13.2. KD Pharma Group
  • 13.3. SEPPIC
  • 13.4. Aker BioMarine AS
  • 13.5. Koninklijke DSM NV
  • 13.6. Croda International Plc
  • 13.7. The Dow Chemical Company
  • 13.8. Arbee Agencies
  • 13.9. Arjuna Natural LLC
  • 13.10. Arctic Nutrition

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us